- Report
- April 2023
- 110 Pages
Global
From €4272EUR$4,750USD£3,763GBP
- Report
- January 2022
- 112 Pages
Global
From €4272EUR$4,750USD£3,763GBP
- Report
- January 2022
- 114 Pages
Global
From €4272EUR$4,750USD£3,763GBP
- Report
- December 2023
- 155 Pages
Global
From €2226EUR$2,475USD£1,961GBP
€4452EUR$4,950USD£3,921GBP
- Report
- February 2024
- 120 Pages
Global
From €4497EUR$5,000USD£3,961GBP
- Report
- February 2024
- 111 Pages
Global
From €4272EUR$4,750USD£3,763GBP
- Report
- February 2024
- 120 Pages
Global
From €4272EUR$4,750USD£3,763GBP
- Report
- August 2022
- 111 Pages
Global
From €4272EUR$4,750USD£3,763GBP
- Report
- January 2025
- 80 Pages
Saudi Arabia
From €3148EUR$3,500USD£2,773GBP
From €3148EUR$3,500USD£2,773GBP
From €3148EUR$3,500USD£2,773GBP
- Report
- August 2024
- 184 Pages
Global
From €4047EUR$4,500USD£3,565GBP
- Report
- July 2024
- 186 Pages
Global
From €4047EUR$4,500USD£3,565GBP
- Report
- May 2024
- 184 Pages
Global
From €4047EUR$4,500USD£3,565GBP
- Report
- May 2024
- 186 Pages
Global
From €4047EUR$4,500USD£3,565GBP
- Report
- May 2024
- 180 Pages
Global
From €4047EUR$4,500USD£3,565GBP
- Report
- April 2024
- 187 Pages
Global
From €4047EUR$4,500USD£3,565GBP
- Report
- April 2024
- 183 Pages
Global
From €4047EUR$4,500USD£3,565GBP
- Report
- April 2024
- 182 Pages
Global
From €4047EUR$4,500USD£3,565GBP
- Report
- April 2024
- 183 Pages
Global
From €4047EUR$4,500USD£3,565GBP

The Drug Discovery market is a sector of the pharmaceutical industry that focuses on the research and development of new drugs. It involves the identification of potential drug targets, the synthesis of new compounds, and the testing of these compounds for efficacy and safety. Companies in this market use a variety of techniques, such as high-throughput screening, computer-aided drug design, and molecular modeling, to identify and develop new drugs.
The Drug Discovery market is highly competitive, with many large pharmaceutical companies and biotechnology firms competing for market share. Some of the major players in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more